---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-029411"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:38:28.413965+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics terminates interim CFO; CEO assumes principal financial officer role

## Summary
- Frances Scally ceased as Interim CFO effective March 29, 2024, following termination of DLA agreement.
- CEO Neil Dey designated as principal financial and accounting officer in addition to CEO role.
- 2024 annual meeting scheduled for May 14, 2024; record date set as April 3, 2024.

## SEC filing metadata
- accession: 0001213900-24-029411
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390024029411/0001213900-24-029411-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390024029411/ea0203115-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-029411
- JSON: https://secwatch.observer/filing/0001213900-24-029411.json
- Plain text: https://secwatch.observer/filing/0001213900-24-029411.txt

## Key facts
- Executive change
  Frances Scally departed as Interim Chief Financial Officer at Bluejay Diagnostics, Inc..
  - Action: ceased serving
  - Role: Interim Chief Financial Officer
  source text: Frances Scally, who had served as the Company’s Interim Chief Financial Officer pursuant to such agreements with DLA, ceased serving as an officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024029411/0001213900-24-029411-index.htm
- Executive change
  Neil Dey changed role as President and Chief Executive Officer (designated as principal financial and accounting officer) at Bluejay Diagnostics, Inc..
  - Action: designated as principal financial and accounting officer
  - Role: President and Chief Executive Officer (designated as principal financial and accounting officer)
  source text: the Board of Directors of the Company (the “Board”) has designated Neil Dey, the Company’s President and Chief Executive Officer, as the Company’s the principal financial and accounting officer, in addition to serving as principal executive officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024029411/0001213900-24-029411-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.